Skip to main content
SpringerLink
Log in
Book cover

Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics pp 5–17Cite as

Oxidative Stress and DNA Damage in Obesity-Related Tumorigenesis

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 824))

Abstract

Reactive oxygen species induce oxidative modification of critical macromolecules. Oxygen derived free radicals may act as potential cytotoxic intermediates inducing inflammatory and degenerative processes, or as signal messengers for the regulation of gene expression. This dual effect mainly depends on the availability of free radicals in terms of concentration, as well as on the environmental characteristics in which they are produced. The formation of free radicals has been proposed to be the linking factor between certain metabolic disturbances and cancer. Circulating mononuclear cells of patients with high cholesterol levels, insulin resistance, metabolic syndrome or obesity present lower levels of antioxidant enzymes and increased concentrations of oxidative stress by-products such as isoprostanes or the DNA oxidized and highly mutagenic base 8-oxo-7,8-dihydro-2′-deoxyguanosine. Overweight or obese subjects also exhibit hormonal changes as a consequence of the increase of mass fat, and these hormonal alterations have been implicated in the alteration of different signal transduction mechanisms and in cell growth and differentiation. A significant correlation has been found between body mass index and cancer. The biological factors and molecular mechanisms implicated in obesity associated cancer susceptibility will be reviewed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Sies H, Cadenas E. Oxidative stress: damage to intact cells and organs. Philos Trans R Soc Lond B Biol Sci. 1985;311:617–31.

    Article  CAS  PubMed  Google Scholar 

  2. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford, UK: Oxford University Press; 2007.

    Google Scholar 

  3. Loft S, Danielson P, Löhr M, Jantzen K, Hemmingsen JG, Roursgaard M, et al. Urinary excretion of 8-oxo-7,8-dihydroguanine as biomarker of oxidative damage to DNA. Arch Biochem Biophys. 2012;518:142–50.

    Article  CAS  PubMed  Google Scholar 

  4. Barregard L, Møller P, Henriksen T, Mistry V, Koppen G, Rossner Jr P, et al. Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine. Antioxid Redox Signal. 2013;18:2377–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Oliva MR, Ripoll F, Muñiz P, Iradi A, Trullenque R, Valls V, et al. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinogen. 1997;18:232–43.

    Article  CAS  Google Scholar 

  6. Oltra AM, Carbonell F, Tormos C, Iradi A, Sáez GT. Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. Free Rad Biol Med. 2001;30:1286–92.

    Article  CAS  PubMed  Google Scholar 

  7. Sánchez M, Torres JV, Tormos C, Iradi A, Muñiz P, Espinosa O, et al. Impairment of antioxidant enzymes, lipid peroxidation and 8-oxo-2′- deoxyguanosine in advanced epithelial ovarian carcinoma of a spanish community. Cancer Lett. 2006;233:28–35.

    Article  PubMed  Google Scholar 

  8. Collado R, Oliver I, Tormos C, Egea M, Miguel A, Cerdá C, et al. Early ROS-mediated DNA damage and oxidative stress biomarkers in monoclonal B lymphocytosis. Cancer Lett. 2012;317:144–9.

    Article  CAS  PubMed  Google Scholar 

  9. Abdilla N, Tormo MC, Fabia MJ, Chaves FJ, Sáez G, Redon J. Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens. 2007;21:68–75.

    Article  CAS  PubMed  Google Scholar 

  10. Martinez-Hervas S, Fandos M, Real JT, Espinosa O, Chaves FJ, Sáez GT, et al. Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis. 2008;199:384–9.

    Article  CAS  PubMed  Google Scholar 

  11. Fandos M, Corella D, Guillén M, Portloés O, Carrasco P, Iradi A, et al. Impact of cardiovascular risk factors on oxidative stress and DNA damage in a high risk Mediterranean population. Free Radic Res. 2009;43:1179–89.

    Article  CAS  PubMed  Google Scholar 

  12. Mitjavila MT, Fandos M, Salas-Salvadó J, Covas MI, Borrego S, Estruch R, et al. The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled trial. Clin Nutr. 2013;32:172–8.

    Article  CAS  PubMed  Google Scholar 

  13. López-Uriarte P, Nogués R, Saez G, Bulló M, Romeu M, Masana L. Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome. Clin Nutr. 2010;29:373–80.

    Article  PubMed  Google Scholar 

  14. Real JT, Martínez-Hervás S, Tormos MC, Domenech E, Pallardó FV, Sáez-Tormo G, et al. Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia. Metabolism. 2010;59:293–8.

    Article  CAS  PubMed  Google Scholar 

  15. Kushino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, et al. Misreading of DNA templates containing 8-hydroxy-deoxyguanosine at the modified base and at adjacent residues. Nature. 1987;327:77–9.

    Article  Google Scholar 

  16. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damage base 8-oxo-Dg. Nature. 1991;349:431–4.

    Article  CAS  PubMed  Google Scholar 

  17. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci U S A. 1999;96:13300–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Lichtman MA. Obesity and the risk for a haematological malignancy: leukemia, lymphoma, or myeloma. Oncologist. 2010;15:1083–101.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Robert DL, Dive C, Renehan AF. Biological mechanisms linking obesity and cancer risk. New perspectives. Annu Rev Med. 2010;61:301–6.

    Article  Google Scholar 

  20. Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. Obes Rev. 2003;4:195–200.

    Article  CAS  PubMed  Google Scholar 

  21. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007;29:1–5.

    Article  PubMed  Google Scholar 

  22. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1:11–25.

    Article  PubMed  Google Scholar 

  23. De Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660–7.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Sánchez-Cruz JJ, Jiménez-Moleón JJ, Fernández-Quesada F, Sánchez MJ. Prevalencia de obesidad infantil y juvenil en España en 2012. Rev Esp Cardiol. 2013;66:371–6.

    Article  Google Scholar 

  25. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults. 1999–2008. JAMA. 2010;303:235–41.

    Article  CAS  PubMed  Google Scholar 

  26. Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev. 2012;21:1244–59.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Haslam D. Obesity: a medical history. Obes Rev. 2007;8 Suppl 1:31–6.

    Article  PubMed  Google Scholar 

  28. Renehan AG, Tyson M, Egger M, Heller F, Swahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.

    Article  PubMed  Google Scholar 

  29. Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res. 2011;4:486–501.

    Article  CAS  Google Scholar 

  30. Ewertz M, Jensen MB, Grunnarsdottir KA, Højris I, Jakobsen EH, Nielsen D, et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol. 2011;29:25–31.

    Article  PubMed  Google Scholar 

  31. Sinicrope FA, Foster NR, Sargent DJ. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010;16:1884–93.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Protani M, Coory M, Marin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627–35.

    Article  PubMed  Google Scholar 

  33. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.

    Article  PubMed  Google Scholar 

  34. Wholin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15:556–65.

    Article  Google Scholar 

  35. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. Brit Med J. 2007;335:1134–9.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Dalling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001;92:720–9.

    Article  Google Scholar 

  37. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–91.

    Article  CAS  PubMed  Google Scholar 

  39. Hsing AW, Sakoda LC, Chua Jr S. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007;86:843–57.

    Google Scholar 

  40. Spindler SR. Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction. Mech Ageing Dev. 2005;126:960–6.

    Article  CAS  PubMed  Google Scholar 

  41. Pallavi R, Giorgio M, Pelicci PG. Insights into the beneficial effect of caloric/dietary restriction for a healthy and prolonged life. Front Physiol. 2012;3:1–10.

    Article  Google Scholar 

  42. Heydari AR, Unnikrishnan A, Lucente LV, Richardson A. Caloric restriction and genomic stability. Nucleic Acids Res. 2007;35:7485–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. McMillan JR, Sattar N, Lean M, McArdle CS. Obesity and cancer. Brit Med J. 2006;333:1109–11.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Lagunova Z, Projnicu AC, Grant WB, Bruland O, Moan JE. Obesity and increased risk of cancer: dose decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association? Mol Nutr Food Res. 2010;54:1127–33.

    CAS  PubMed  Google Scholar 

  45. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3:687–95.

    CAS  PubMed  Google Scholar 

  46. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6:164–79.

    Article  CAS  PubMed  Google Scholar 

  47. Frystyk J. Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res. 2004;14:337–75.

    Article  CAS  PubMed  Google Scholar 

  48. Becker S, Lossus L, Kaaks R. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem. 2009;115:86–96.

    Article  CAS  PubMed  Google Scholar 

  49. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem. 2008;114:63–70.

    Article  CAS  PubMed  Google Scholar 

  50. Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, et al. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk: results from the European prospective investigation into cancer and nutrition. Int J Cancer. 2007;120:2656–64.

    Article  CAS  PubMed  Google Scholar 

  51. Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, et al. Serum C-peptide levels and breast cancer risk: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2006;119:659–67.

    Article  CAS  PubMed  Google Scholar 

  52. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab. 2006;17:328–36.

    Article  CAS  PubMed  Google Scholar 

  53. Richart W, Fernandez-Real JM. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance. Obes Res. 2001;9:631–6.

    Article  Google Scholar 

  54. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factor and neoplasia. Nat Rev Cancer. 2004;4:505–18.

    Article  CAS  PubMed  Google Scholar 

  55. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res. 2002;62:1030–5.

    CAS  PubMed  Google Scholar 

  56. Heron-Milhavet L, LeRoith D. Insulin-like growth factor I induces MDM-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage. J Biol Chem. 2002;18:15600–6.

    Article  Google Scholar 

  57. Canonici A, Steelant W, Rigot V, Khomitch-Baud A, Boutaghou-Cherid H, Bruyneel E. Insulin-like growth factor-I receptor, E-cadherin and alpha v integrin form a dynamic complex under the control of alpha-catenin. Int J Cancer. 2008;122:572–82.

    Article  CAS  PubMed  Google Scholar 

  58. Bray GA. The underlying basis for obesity: relationship to cancer. J Nutr. 2002;132:3451s–5.

    CAS  PubMed  Google Scholar 

  59. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev. 2004;5:153–65.

    Article  CAS  PubMed  Google Scholar 

  60. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology. 2001;121:79–90.

    Article  CAS  PubMed  Google Scholar 

  61. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R, Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun. 2002;293:622–8.

    Article  CAS  PubMed  Google Scholar 

  62. Barb D, Williams CJ, Neuwirth AK, Mantzoros CS. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr. 2007;86:s858–66.

    PubMed  Google Scholar 

  63. Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;2012:789174.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, et al. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab. 2003;88:993–7.

    Article  CAS  PubMed  Google Scholar 

  65. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res. 2003;9:5699–704.

    CAS  PubMed  Google Scholar 

  66. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S, et al. Prostate cancer and adiponectin. Urology. 2005;65:1168–72.

    Article  PubMed  Google Scholar 

  67. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst. 2005;97:1688–94.

    Article  CAS  PubMed  Google Scholar 

  68. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R. Adiponectin mediates antiproliferative and apoptotic response in human MCF7 breast cancer cells. Boichem Biophys Res Commun. 2006;345:271–8.

    Article  CAS  Google Scholar 

  69. Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, et al. Adiponectin induced antiangiogenic and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A. 2004;101:2476–81.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative-stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752–61.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  71. Rindler PM, Plafker SM, Szweda LI, Kinter M. High dietary fat selectively increases catalase expression within cardiac mitochondria. J Biol Chem. 2013;288:1979–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  72. Dröse S, Brandt U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol. 2012;748:145–69.

    Article  PubMed  Google Scholar 

  73. Diaz-Marco MT, Moscat J. The atypical PKCs in inflammation: NFkB and beyond. Immunol Rev. 2012;246:154–67.

    Article  Google Scholar 

  74. Patel C, Ghanim H, Ravishankar S, Sia CL, Viswanathan P, Mohanty P, et al. Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J Clin Endocrinol Metabol. 2007;92:4476–9.

    Article  CAS  Google Scholar 

  75. Bubici C, Papa S, Dean K, Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene. 2006;25:6731–48.

    Article  CAS  PubMed  Google Scholar 

  76. Surmi BK, Hasty AH. The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue. Vasc Pharmacol. 2010;52:27–36.

    Article  CAS  Google Scholar 

  77. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236:313–22.

    Article  CAS  PubMed  Google Scholar 

  78. Shin S, Wakabayashi J, Yates MS, Wakabayashi N, Dolan PM, Aja S, et al. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol. 2009;620:138–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  79. Brown LA, Kerr CJ, Whiting P, Finer N, McEneny J, Ashton T. Oxidant stress in healthy normal-weight, overweight, and obese individuals. Obesity. 2009;17:460–6.

    Article  CAS  PubMed  Google Scholar 

  80. Savini I, Catani MV, Evangelista D, Gasperi V, Avigliano L. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci. 2013;14:10947–538.

    Article  Google Scholar 

  81. Ferretti G, Bacchetti T, Masciangelo S, Bicchiega V. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects. Obesity. 2010;18:1079–84.

    Article  CAS  PubMed  Google Scholar 

  82. Krzystek-Korpacka M, Patryn E, Hotowy K, Czapińska E, Majda J, Kustrzeba-Wójcicka I, et al. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress. Adv Clin Exp Med. 2013;22:229–36.

    PubMed  Google Scholar 

  83. Ferré N, Feliu A, García-Heredia A, Marsillach J, París N, Zaragoza-Jordana M, et al. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome. Clin Biochem. 2013;46:1830–6.

    Article  PubMed  Google Scholar 

  84. Canoy D, Wareham N, Welch A, Bingham S, Luben R, Day N, Khaw KT. Plasma ascorbic acid concentrations and fat distribution in 19,068 British men and women in the European prospective investigation into cancer and nutrition Norfolk cohort study. Am J Clin Nutr. 2005;82:1203–9.

    CAS  PubMed  Google Scholar 

  85. D’Archivio M, Annuzzi G, Varì R, Filesi C, Giacco R, Scazzocchio B, et al. Predominant role of obesity/insulin resistance in oxidative development. Eur J Clin Invest. 2012;42:70–8.

    Article  PubMed  Google Scholar 

  86. De Tursi-Ríspoli L, Vázquez-Tarragón A, Vázquez-Prado A, Sáez-Tormo G, Alí-Mahmoud A, Gumbau-Puchol V. Estrés oxidativo; estudio comparativo entre un grupo de población normal y un grupo de población obesa mórbida. Nutr Hosp. 2013;28:671–5.

    PubMed  Google Scholar 

  87. De Tursi-Ríspoli L, Vázquez-Tarragón A, Vázquez-Prado A, Sáez-Tormo G, Mahmoud AL, Bruna-Esteban M, et al. Relationship of oxidative stress and weight loss achieved in morbid obese patients by means of bariatric surgery using the duodenal switch technique. Nutr Hosp. 2013;28:1085–92.

    PubMed  Google Scholar 

  88. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448–54.

    Article  PubMed  Google Scholar 

  89. Il’yasova D, Wang F, Spasojevic I, Base K, D’Agostino Jr RB, Wagenknecht LE. Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort. Obesity (Silver Spring). 2012;20:1915–21.

    Article  Google Scholar 

  90. Kanaya AM, Wassel CL, Stoddard PJ, Harris TB, Cummings SR, Kritchevsky SB, et al. F2-isoprostanes and adiposity in older adults. Obesity (Silver Spring). 2011;19:861–7.

    Article  CAS  Google Scholar 

  91. Zhang H, Xie C, Spencer HJ, Zuo C, Higuchi M, Ranganathan G, et al. Obesity and hepatosteatosis in mice with enhanced oxidative DNA damage processing in mitochondria. Am J Pathol. 2011;178:1715–27.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  92. Sampath H, Vartanian V, Rollins MR, Sakumi K, Nakabeppu Y, Lloyd RS. 8-Oxoguanine DNA glycosilase (OGG1) deficiency increases susceptibility to obese and metabolic dysfunction. PLoS One. 2012;7:e51697.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  93. García-Heredia A, Kensicki E, Mohney RP, Rull A, Triguero I, Marsillach J, et al. Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet. A metabolomic approach. J Proteome Res. 2013;12:1946–55.

    Article  PubMed  Google Scholar 

  94. Milić M, Kišan M, Rogulj D, Radman M, Lovrenčić MV, Konjevoda P, et al. Level of primary DNA damage in the early stage of metabolic syndrome. Mutat Res. 2013;758:1–5.

    Article  PubMed  Google Scholar 

  95. Anderson D, Yu TW, Wright J, Ioannides C. An explanation of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients. Mutat Res. 1998;398:151–61.

    Article  CAS  PubMed  Google Scholar 

  96. Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril. 2010;93:2222–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  97. Dupont C, Faure C, Sermondade N, Boubaya M, Eustache F, Clément P, et al. Obesity leads to higher risk of sperm DNA damage in infertile patients. Asian J Androl. 2013;15:622–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgements

GTS thanks grants from Conselleria de Sanitat de la Generalitat de València and Instituto de Salud Carlos III: ACOM/2012/238; PI10/00802; PI13/01848; CIBEROBN 12/03/30016

Author information

Authors and Affiliations

  1. Service of Clinical Analysis-CDB, Oxidative Stress Commission-SEQC, General University Hospital-CIBEROBN, University of Valencia, Valencia, Spain

    Concha Cerdá, Ana Bediaga & Guillermo T. Sáez

  2. Endocrinology and Nutrition Unit, General University Hospital, University of Valencia, Valencia, Spain

    Carlos Sánchez

  3. Service of Internal Medicine, General University Hospital, University of Valencia, Valencia, Spain

    Benjamín Climent

  4. Service of General and Digestive Surgery, General University Hospital, University of Valencia, Valencia, Spain

    Antonio Vázquez

  5. Department of Physiology, Faculty of Medicine-CIBEROBN, University of Valencia, Valencia, Spain

    Antonio Iradi

  6. Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Valencia, Avda. Blasco Ibañez 15, 46010, Valencia, Spain

    Fátima El Amrani

  7. Department of Biochemistry and Molecular Biology, Faculty of Medicine, General University Hospital-CDB, University of Valencia, Oxidative Stress Commission-SEQC, Avda. Blasco Ibañez 15, 46010, Valencia, Spain

    Guillermo T. Sáez

Authors
  1. Concha Cerdá
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamín Climent
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonio Vázquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Iradi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fátima El Amrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ana Bediaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Guillermo T. Sáez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guillermo T. Sáez .

Editor information

Editors and Affiliations

  1. Hospital Universitari de Sant Joan, IISPV, URV, Unitat de Recerca Biomèdica, Reus, Spain

    Jordi Camps

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cerdá, C. et al. (2014). Oxidative Stress and DNA Damage in Obesity-Related Tumorigenesis. In: Camps, J. (eds) Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics. Advances in Experimental Medicine and Biology, vol 824. Springer, Cham. https://doi.org/10.1007/978-3-319-07320-0_2

Download citation

Publish with us

Policies and ethics

Search

Navigation